Literature DB >> 11105828

"FUR"--one size suits all.

M Rutland1, L Que, I M Hassan.   

Abstract

This work used amalgamated data from previous projects in order to test the concept that when organ function is expressed in terms of tracer kinetics, the results are independent of patient size or gender. Dynamic gamma camera studies were analysed by measuring the rate of movement of tracers from the blood into various organs. These rates were expressed as a "fractional uptake rate" (FUR), which is the fraction of tracer in the blood taken up by the organ per unit time. As these values were small, it was convenient to express the FUR per million seconds. The FUR was calculated using the expression FUR = SLOPE (of Rutland-Patlak plot), multiplied by B(0) (the blood curve value back-extrapolated to time zero), and divided by the TOTAL amount of tracer injected. Data were used from adult patients between the ages of 20 and 49 years who had normal organ function. Organ/tracer groups studied were the skeletal uptake of 99mTc-MDP, the renal uptake of 99mTc-MAG3, the renal uptake of 99mTc-MDP, the renal uptake of 99mTc-DTPA, the hepatic uptake of 99mTc-colloid, the splenic uptake of 99mTc-colloid, and the hepatic uptake of 99mTc-DISIDA. Each organ/tracer group was divided into three subgroups according to patient size (smallest, middle and largest), and also into subgroups according to gender. Comparison of these subgroups did not show any significant size- or gender-related differences in FUR values. It is concluded that for patients with normally functioning organs the FUR is independent of patient size or gender. Thus, the FUR is a valuable way of expressing organ function, particularly in patients with unusual or rapidly changing body size, such as children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11105828     DOI: 10.1007/s002590000337

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Assessment of artery calcification in atherosclerosis with dynamic 18F-FDG-PET/CT imaging in elderly subjects.

Authors:  Mamdouh S Al-Enezi; Redha-Alla Abdo; Mohamed Yazid Mokeddem; Faiçal A A Slimani; Abdelouahed Khalil; Tamas Fulop; Eric Turcotte; M'hamed Bentourkia
Journal:  Int J Cardiovasc Imaging       Date:  2019-02-02       Impact factor: 2.357

2.  99mTc-MAG3 scintigraphy for the longitudinal follow-up of kidney function in a mouse model of renal ischemia-reperfusion injury.

Authors:  Tanja Herrler; Hao Wang; Anne Tischer; Peter Bartenstein; Karl-Walter Jauch; Markus Guba; Markus Diemling; Cyril Nimmon; Marcus Hacker
Journal:  EJNMMI Res       Date:  2012-01-20       Impact factor: 3.138

3.  Comparison of different quantification methods for 18F-fluorodeoxyglucose-positron emission tomography studies in rat brains.

Authors:  Silvana Prando; Camila de Godoi Carneiro; Cecil Chow Robilotta; Marcelo Tatit Sapienza
Journal:  Clinics (Sao Paulo)       Date:  2019-09-26       Impact factor: 2.365

4.  Comparison between a dual-time-window protocol and other simplified protocols for dynamic total-body 18F-FDG PET imaging.

Authors:  Zhenguo Wang; Yaping Wu; Xiaochen Li; Yan Bai; Hongzhao Chen; Jie Ding; Chushu Shen; Zhanli Hu; Dong Liang; Xin Liu; Hairong Zheng; Yongfeng Yang; Yun Zhou; Meiyun Wang; Tao Sun
Journal:  EJNMMI Phys       Date:  2022-09-14

5.  Nephroprotective effects of enalapril after [177Lu]-DOTATATE therapy using serial renal scintigraphies in a murine model of radiation-induced nephropathy.

Authors:  Harun Ilhan; Hao Wang; Franz J Gildehaus; Carmen Wängler; Tanja Herrler; Andrei Todica; Julia Schlichtiger; Paul Cumming; Peter Bartenstein; Marcus Hacker; Alexander R Haug
Journal:  EJNMMI Res       Date:  2016-08-11       Impact factor: 3.138

6.  Complex Monitoring of Biochemical and Radionuclide Parameters in Patients with Metastatic Renal Cell Carcinoma during Immunotherapy.

Authors:  M S Sayapina; S G Averinova; T V Zacharova; A V Kashkadaeva; S V Shiryaev; M V Poluectova; O A Vorob'eva
Journal:  Int J Nephrol       Date:  2017-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.